Last Update Time:
20-Mar-2025 16:00:00
ISIN:
INE668F01031
Sector:
Fast Moving Consumer Goods
Symbol:
JYOTHYLAB
Jyothy Labs Limited
₹337.90
₹6.25
(1.88%)
▲
Prev. Close
₹331.65
Open
₹333.05
Close
₹337.25
Range
₹321.01 - ₹354.80
High
₹341.10
Low
₹330.75
Ind. Close
₹0.00
VWAP
₹335.81
The current stock price of Jyothy Labs Limited is ₹337.90, with a target price range between ₹321.01 and ₹354.80. The stock has experienced a price change of ₹6.25 (1.88%), reflecting recent market volatility.
Today's opening price was ₹333.05, while the previous close stood at ₹331.65.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Jyothy Labs Limited Price Chart
Jyothy Labs Limited Pre Open Market Overview: 20-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 333.05
- Previous Close Price: 331.65
- Change: 1.40%
- Total Traded Volume: 1,648
- Total Buy Quantity: 17,602
- Total Sell Quantity: 28,849
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 332.25 | 1.00 | 0.00 |
| 332.30 | 10.00 | 0.00 |
| 332.95 | 30.00 | 0.00 |
| 333.00 | 119.00 | 0.00 |
| 333.05 | 538.00 | 0.00 |
| 333.40 | 0.00 | 116.00 |
| 333.80 | 0.00 | 50.00 |
| 333.90 | 0.00 | 100.00 |
| 333.95 | 0.00 | 2,400.00 |
| 334.10 | 0.00 | 23.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 17602
Total Sell Quantity: 28849
Shareholding Patterns of Jyothy Labs Limited
Key Trade Statistics of Jyothy Labs Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 12.05 |
| Traded Value (₹ Cr.) | 40.45 |
| Total Market Cap (₹ Cr.) | 12,408.18 |
| Free Float Market Cap (₹ Cr.) | 4,587.73 |
| Impact cost | 0.07 |
| Quantity Traded | 1,204,571.00 |
| Deliverable Quantity | 668,370.00 |
| % of Quantity to Traded | 55.49 |
| Security VaR | 14.98 |
| Index VaR | N/A |
| VaR Margin | 14.98 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 18.48 |
| Face Value | 1 |
Key Price Statistics of Jyothy Labs Limited
The 52-week high for Jyothy Labs Limited was ₹595.85, recorded on 11-Sep-2024. On the other hand, the 52-week low stands at ₹310.20, with the lowest value recorded on 04-Mar-2025.
The upper band for trading is ₹397.95, and the lower band is ₹265.35. The price band is 20%.
The stock's daily volatility stands at 2.33, while the annualized volatility is 44.51. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (11-Sep-2024) | 595.85 |
| 52 Week Low (04-Mar-2025) | 310.20 |
| Upper Band | 397.95 |
| Lower Band | 265.35 |
| Price Band (%) | 20 |
| Daily Volatility | 2.33 |
| Annualised Volatility | 44.51 |
| Tick Size | 0.05 |
Key Securities Statistics of Jyothy Labs Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 19-Dec-2007 |
| Adjusted P/E | 32.72 |
| Symbol P/E | 32.72 |
| Index | NIFTY 500 |
| Macro-Economic Sector | Fast Moving Consumer Goods |
| Sector | Fast Moving Consumer Goods |
| Industry | Household Products |
| Basic Industry | Household Products |
Security Status of Jyothy Labs Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Jyothy Labs Limited
| Subject | Date |
|---|---|
| General Updates | 19-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 10-Mar-2025 |
| Product launch | 01-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 28-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 28-Feb-2025 |
| General Updates | 21-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 17-Feb-2025 |
| Press Release | 14-Feb-2025 |
Corporate Actions of Jyothy Labs Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 1 | Annual General Meeting/Dividend - Rs 3.50 Per Share | 03-Jul-2024 |
| 1 | Annual General Meeting/Dividend - Rs 3 Per Share | 03-Jul-2023 |
| 1 | Annual General Meeting/Dividend - Rs 2.50 Per Share | 01-Jul-2022 |
| 1 | Annual General Meeting/Dividend - Rs 4 Per Share | 20-Jul-2021 |
| 1 | Annual General Meeting | 29-Jul-2020 |
| 1 | Interim Dividend - Rs 3 Per Share | 19-Mar-2020 |
| 1 | Annual General Meeting/Dividend - Rs 3 Per Share | 12-Jul-2019 |
| 1 | Annual General Meeting / Dividend- Rs 0.50 Per Share | 16-Jul-2018 |
| 1 | Bonus 1:1 | 28-Jun-2018 |
| 1 | Annual General Meeting/Dividend - Rs 6/- Per Share | 03-Jul-2017 |
| 1 | Annual General Meeting And Dividend Re.1/- Per Share | 14-Jul-2016 |
| 1 | Interim Dividend - Re 4/- Per Share (Purpose Revised) | 17-Mar-2016 |
| 1 | Annual General Meeting/Dividend - Rs 4/- Per Share | 15-Jul-2015 |
| 1 | Annual General Meeting / Final Dividend - Rs 2/- Per Share | 31-Jul-2014 |
| 1 | Interim Dividend - Re 1/- Per Share | 06-Feb-2014 |
| 1 | Annual General Meeting/Dividend Rs 2.50/- Per Share | 25-Jul-2013 |
| 1 | Annual General Meeting/Dividend Of Rs.2.50 Per Share/ Bonus 1:1 | 12-Jul-2012 |
| 1 | Annual General Meeting And Dividend Rs.5/- Per Share | 08-Sep-2011 |
| 1 | Annual General Meeting And Dividend Rs.4/- Per Share | 15-Jul-2010 |
| 1 | Agm/Div-Rs.2/- Per Share | 16-Jul-2009 |
Board Meetings of Jyothy Labs Limited
Financial Results of Jyothy Labs Limited
Company Directory of Jyothy Labs Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.jyothylaboratories.com | Registered Office | Ujala House, Ram Krishna Mandir Road, Kondivita, Andheri (East) | MUMBAI |
| www.jyothylaboratories.com | Transfer Agent | Link Intime India Private Limited C 101, 247 Park L B S Marg Vikhroli (West) | MUMBAI |
Insider Trading of Jyothy Labs Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | M. P. Ramachandran | 0 | Sell |
| 7(2) | M. G. Shanthakumari | 0 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 39054 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 141929 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 165225 | Sell |
| 7(2) | Harathy Kasthuri Veera Raghavan | 219576 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 224207 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 87170 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 90003 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 44005 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 182754 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 88762 | Sell |
| 7(2) | Harathy Kasthuri Veera Raghavan | 82021 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 264252 | Sell |
| 7(2) | Harathy Kasthuri Veera Raghavan | 169447 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 73059 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 66669 | Sell |
| 7(2) | Harathy Kasthuri Veera Raghavan | 62036 | Buy |
| 7(2) | Harathy Kasthuri Veera Raghavan | 42008 | Sell |
| 7(2) | Harathy Kasthuri Veera Raghavan | 20820 | Sell |
Annual Reports of Jyothy Labs Limited
Investor Complaints of Jyothy Labs Limited
Event Calendar of Jyothy Labs Limited
| Purpose | Details |
|---|---|
| Results/Dividend | To consider inter-alia the following: (a) Results of the Company for the Financial Period ended March 31, 2009 (9 Months), & (b) Declaration of dividend, if any, for the said Financial Period. |
| Results/Dividend | To consider inter alia the following: (1) Results of the Company for the Financial Year ended March 31, 2010. (2) Declaration of Dividend, if any, for the said Financial Year. |
| Results/Dividend | To consider inter-alia the following: (a) Results of the Company for the Financial Year ended March 31, 2011; and (b) Declaration of dividend, if any, for the said Financial Year. |
| Results/Dividend | To consider inter-alia the following : (a) Results of the Company for the Financial Year ended March 31, 2012; and (b) Declaration of dividend, if any, for the said Financial Year. |
| Scheme of Arrangement | Inter alia, to consider following : (1) The proposal of Amalgamation of Henkel India Limited (HIL), with Jyothy Laboratories Limited (JLL); (2) The Scheme of Amalgamation between HIL and JLL; (3) The Valuation report for the purpose of exchange ratio; (4) The Fairness Opinion; (5) Other matters incidental and connected to the said amalgamation between HIL and JLL. |
| Results/Dividend | To consider inter-alia the following : (a) Results of the Company for the Financial Year ended March 31, 2013, & (b) Declaration of dividend, if any, for the said Financial Year. |
| Results | Inter-alia to consider the Un-Audited Financial Results of the Company for the 1st Quarter ended June 30, 2013. |
| Results | Inter-alia to consider the Un-Audited Financial Results of the Company for the 2nd Quarter ended September 30, 2013. |
| Results | Inter-alia to consider the Un-Audited Financial Results of the Company for the 3rd Quarter ended December 31, 2013. |
| Results/Dividend | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on January 28, 2014 inter-alia to consider the Un-Audited Financial Results of the Company for the 3rd Quarter ended December 31, 2013. The Company has now informed the Exchange that the Board of Directors will also consider declaration of interim dividend for the financial year 2013-2014. (purpose revised) |
| Results/Dividend | To consider inter-alia the following : (a) Results of the Company for the Financial Year ended March 31, 2014, and (b) Declaration of dividend, if any, for the said financial year. |
| Results | To consider inter-alia the Un-Audited Financial Results of the Company for the 1st Quarter ended June 30, 2014. |
| Results | Inter-alia to consider the Un-Audited Standalone and Consolidated Financial Results of the Company for the 2nd quarter and half year ended September 30, 2014. |
| Results | Inter-alia to consider the Un-Audited Standalone and Consolidated Financial Results of the Company for the 3rd quarter and nine months ended December 31, 2014. |
| Results/Dividend | Inter-alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter / year ended March 31, 2015 and to recommend dividend, if any, for the said financial year. |
| Results | To consider inter-alia the Un-Audited Standalone and Consolidated Financial Results of the Company for the 1st Quarter ended June 30, 2015. |
| Results | To consider inter-alia the Un-Audited Standalone and Consolidated Financial Results of the Company for the 2nd Quarter/ Half Year ended September 30, 2015. |
| Results/Others | To consider inter-alia the Un-Audited Standalone and Consolidated Financial Results of the Company for the 3rd Quarter/ Nine months ended December 31, 2015. |
| Dividend | To consider, inter-alia, the declaration of Interim Dividend on the Equity Shares of the Company for the financial year 2015-16. |
| Results/Dividend | Inter-alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2016 and to consider and recommend final dividend, if any, on the Equity Shares of the Company for the financial year 2015-16. |
| Results | Inter-alia, to consider and approve Un-Audited Standalone and Consolidated Financial Results of the Company subject to Limited Review by the Statutory Auditors of the Company for the quarter ended June 30, 2016. |
| Results | consent of the shareholders of the Company for the issue of non-convertiable debt securities, if approved by the Board of Directors at its meeting schedule to be held on 25th October, 2016, will be sought by way of postal ballot. |
| Results/Others | Inter alia, to consider and approve Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2016 subject to Limited Review by the Statutory Auditors of the Company. Further the Board of Directors will also consider the proposal of raising funds though issue of non-convertible debt securities at the same meeting. |
| Raising of Funds | Inter-alia, to consider the proposal of raising funds through issuance of new non-convertible debt securities on private placement basis. |
| Results | inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2016 subject to Limited Review by the Statutory Auditors of the Company |
| Results/Dividend | Inter alia, to consider and approve audited financial results for the quarter and financial year ended March 31,2017 and to consider and recommend dividend, if any, on the Equity Shares of the Company for the financial year 2016-17. |
| Results | Inter-alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company with limited review by the Statutory Auditors of the Company. |
| Results | inter-alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2017 with limited review by the Statutory Auditors of the Company. |
| Results | Inter-alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2017 with limited review by the Statutory Auditors of the Company |
| Financial Results/Dividend/Fund Raising | To consider and approve the financial results for the period ended March 31, 2018, dividend and Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Dividend | Consider and approve declaration of Interim for the Financial Year 2019-20 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and consider recommendation of dividend, if any, on the equity shares of the Company for thefinancial year 2020-21 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Jyothy Labs Limited has informed the Exchange about Board Meeting to be held on 25-Jul-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Jyothy Labs Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | The Meeting of the Board of Directors of Jyothy Labs Limited is scheduled to be held on Wednesday, January 25, 2023, inter-alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended December 31, 2022, with limited review thereon by the Statutory Auditors of the Company. |
| Financial Results/Dividend | To consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2023 and consider recommendation of dividend, if any, on the equity shares of the Company for the financial year 2022-23 |
| Financial Results | The meeting of the Board of Directors of Jyothy Labs Limited is scheduled to be held on Tuesday, July 25, 2023, inter-alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter ended June 30, 2023, with limited review thereon by the Statutory Auditors of the Company. |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | Intimation of Board Meeting scheduled to be held on Tuesday, November 12, 2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the quarter and half year ended September 30, 2024. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Jyothy Labs Limited
Voting Results of Jyothy Labs Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 25-JUL-2024 | AGM | Adoption of the Audited Standalone and Consolidated Financial Statements for the Financial Year ended March 31, 2024 and the reports of the Board of Directors and Statutory Auditors thereon. |
| 25-JUL-2024 | AGM | Re-appointment of Ms. M. R. Jyothy (DIN: 00571828) as the Chairperson and Managing Director of the Company, for a period of 5 (Five) years with effect from April 1, 2025 to March 31, 2030 (both days inclusive) on key terms and conditions including remuneration as specified in the resolution. |
| 25-JUL-2024 | AGM | Approval of payment of remuneration to Cost Auditors. |
| 25-JUL-2024 | AGM | Appointment of Director in place of Ms. M. R. Jyothy (DIN: 00571828), who retires by rotation and being eligible, offers herself for re-appointment. |
| 25-JUL-2024 | AGM | Declaration of final dividend of Rs. 3.50 per equity share of face value of Rs. 1 each of the Company for the Financial Year 2023-24. |
| 07-MAR-2024 | Postal Ballot | 1. Appointment of Mr. Ananth Rao T (DIN: 02585410) as a Director of the Company |
| 07-MAR-2024 | Postal Ballot | 6. Appointment of Mr. Suresh Balakrishna (DIN: 05207871) as an Independent Director of the Company for a period of 5 (Five) consecutive years commencing from April 1, 2024 up to March 31, 2029 (both days inclusive) |
| 07-MAR-2024 | Postal Ballot | 5. Appointment of Mr. Narayanan Subramaniam (DIN: 00166621) as an Independent Director of the Company for a period of 5 (Five) consecutive years commencing from December 15, 2023 up to December 14, 2028 (both days inclusive) |
| 07-MAR-2024 | Postal Ballot | 4. Appointment of Mr. Ravi Razdan (DIN: 08936083) as a Whole time Director designated as ￢ﾀﾜDirector ￢ﾀﾓ IT & HR￢ﾀﾝ of the Company for a period of 5 (five) consecutive years with effect from April 1, 2024 to March 31, 2029 (both days inclusive), liable to retire by rotation |
| 07-MAR-2024 | Postal Ballot | 3. Appointment of Mr. Ravi Razdan (DIN: 08936083) as a Director of the Company |
| 07-MAR-2024 | Postal Ballot | 2. Appointment of Mr. Ananth Rao T (DIN: 02585410) as a Whole time Director designated as ￢ﾀﾜDirector ￢ﾀﾓ Operations & Commercial￢ﾀﾝ of the Company for a period of 5 (five) consecutive years with effect from April 1, 2024 to March 31, 2029 (both days inclusive), liable to retire by rotation |
| 25-JUL-2023 | AGM | Adoption od the Audited Standalone and Consolidated Financial Statements for the Financial Year ended March 31, 2023 and the reports of the Board of Directors and Statutory Auditors thereon |
| 25-JUL-2023 | AGM | Approval for introduction and implementation of Employee Stock Option Scheme viz. 'Jyothy Labs Limited - Restricted Stock Unit Plan 2023' ('RSU Plan 2023'/ Plan) in accordance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 |
| 25-JUL-2023 | AGM | Re-appointment of Ms. Bhumika Batra (DIN: 03502004) as an Independent Director of the Company, not liable to retire by rotation, for a second term of 5 (five) consecutive years commencing from March 14, 2024 up to March 13, 2029 (both days inclusive) |
| 25-JUL-2023 | AGM | Ratification of remuneration of Cost Auditors |
| 25-JUL-2023 | AGM | Appointment of Director in place of Ms. M. R. Jyothy (DIN: 00571828), who retires by rotation and being eligible, offers for re-appointment |
| 25-JUL-2023 | AGM | Declaration of dividend on equity shares of the Company for the Financial Year 2022-23 |
| 25-JUL-2022 | AGM | Adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2022 and the reports of the Board of Directors and Statutory Auditors thereon. |
| 25-JUL-2022 | AGM | Appointment of Director in place of Ms. M. R. Deepthi (DIN: 01746698), who retires by rotation and being eligible, offers herself for re-appointment. |
| 25-JUL-2022 | AGM | Declaration of dividend on equity shares of the Company for the Financial Year 2021-22. |
FAQs on Jyothy Labs Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.